If you add up all the promissory notes(CMP, OLAREG

If you add up all the promissory notes(CMP, OLAREGEN, VENETO, DISCOVER, AUCTUS etc) and associated litigation GNBT is in financial trouble. Recent 8/10kA are great, references of support by big names but no financial investments says it all........ These companies imo are all part of the BARDA app, research/production will be compensated if approved. I like to see a breakdown of the 1.3/2B calculations...... cost to produce vaccine , how many units/cost and estimated revenue ??? If not approved some mentioned the company will continue to develop vaccine..........at what cost? Unless NASDAQ listed and institutional support this company won't go anywhere and the selling of miscalculated deals and unnecessary issued divis will continue until the pps returns to single digits. It's truly Vegas with Covid on green 0.